What Is Driving the Growth of the United States Hereditary Angioedema Therapeutics Market?
The United States hereditary angioedema therapeutics market has witnessed a substantial transformation in recent years, fueled by advancements in genetic therapies, improved diagnostic awareness, and novel biologic drug launches. Valued at USD 5.18 billion in 2024, the market is projected to expand at an impressive CAGR of 13.10% between 2025 and 2034, ultimately reaching USD 17.74 billion by...
0 Commentaires
0 Parts
279 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt